3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      A novel E2F/sphingosine kinase 1 axis regulates anthracycline response in squamous cell carcinoma.

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Head and neck squamous cell carcinomas (HNSCC) are frequently drug resistant and have a mortality rate of 45%. We have previously shown that E2F7 may contribute to drug resistance in SCC cells. However, the mechanism and pathways involved remain unknown.

          Related collections

          Author and article information

          Journal
          Clin. Cancer Res.
          Clinical cancer research : an official journal of the American Association for Cancer Research
          American Association for Cancer Research (AACR)
          1078-0432
          1078-0432
          Jan 15 2015
          : 21
          : 2
          Affiliations
          [1 ] Epithelial Pathobiology Group, University of Queensland Diamantina Institute, Princess Alexandra Hospital, Translational Research Institute, Woolloongabba, Queensland, Australia.
          [2 ] Department of Pathology, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia.
          [3 ] Department of Medical Oncology, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia.
          [4 ] Epithelial Pathobiology Group, University of Queensland Diamantina Institute, Princess Alexandra Hospital, Translational Research Institute, Woolloongabba, Queensland, Australia. nsaunders@uq.edu.au.
          Article
          1078-0432.CCR-14-1962
          10.1158/1078-0432.CCR-14-1962
          25411162
          ca6ba93b-cb30-4ba7-8183-e5e34defd1eb
          History

          Comments

          Comment on this article